|
MAP2K2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.43920000051612E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18109999999827E-05 |
| Normal-vs-Stage2 |
3.847500E-04 |
| Normal-vs-Stage3 |
9.551100E-04 |
| Normal-vs-Stage4 |
2.344000E-02 |
| Stage1-vs-Stage2 |
1.512170E-01 |
| Stage1-vs-Stage3 |
6.193600E-01 |
| Stage1-vs-Stage4 |
5.832600E-01 |
| Stage2-vs-Stage3 |
4.654200E-01 |
| Stage2-vs-Stage4 |
1.308950E-01 |
| Stage3-vs-Stage4 |
4.005600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.13069999999549E-05 |
| Normal-vs-AfricanAmerican |
5.581400E-03 |
| Normal-vs-Asian |
1.203340E-03 |
| Caucasian-vs-AfricanAmerican |
2.631000E-01 |
| Caucasian-vs-Asian |
2.591600E-01 |
| AfricanAmerican-vs-Asian |
8.210600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92807999999101E-05 |
| Normal-vs-Female |
2.20689999999024E-05 |
| Male-vs-Female |
1.607370E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.36940000000785E-05 |
| Normal-vs-Age(41-60Yrs) |
2.759200E-04 |
| Normal-vs-Age(61-80Yrs) |
7.430600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.480000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.539800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.678400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.695400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.691000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.701400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.773200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.192400E-02 |
| Classical-VS-Follicular |
7.721500E-02 |
| Classical-VS-Other |
7.019600E-01 |
| Classical-VS-Normal |
2.584200E-04 |
| Tall-VS-Follicular |
2.841900E-03 |
| Tall-VS-Other |
1.346020E-01 |
| Tall-VS-Normal |
4.937000E-01 |
| Follicular-VS-Other |
8.372400E-01 |
| Follicular-VS-Normal |
2.00929999999433E-05 |
| Other-VS-Normal |
2.976300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.38670005770337E-10 |
| Normal-vs-N1 |
1.873750E-02 |
| N0-vs-N1 |
8.488500E-02 |
|
|
